References
- DubeauLThe cell of origin of ovarian epithelial tumoursLancet Oncol20089121191119719038766
- SiegelRLMillerKDJemalAStatistics C. Cancer statistics, 2016CA Cancer J Clin201666173026742998
- DavisATinkerAVFriedlanderM“Platinum resistant” ovarian cancer: what is it. Who to treat and how to measure benefit?Gynecol Oncol2014133362463124607285
- SlaughterKHolmanLLThomasELPrimary and acquired platinum-resistance among women with high grade serous ovarian cancerGynecol Oncol2016142222523027208536
- DumicJDabelicSFlögelMGalectin-3: an open-ended storyBiochim Biophys Acta20061760461663516478649
- OishiTItamochiHKigawaJGalectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovaryInt J Gynecol Cancer20071751040104617433067
- LinCIWhangEEAbramsonMAGalectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cellsBiochem Biophys Res Commun2009379262663119124005
- LuHLiuYWangDGalectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathwayTumour Biol2016378114691147727012551
- ShimuraTTakenakaYFukumoriTImplication of galectin-3 in Wnt signalingCancer Res20056593535353715867344
- de SousaEMeloFVermeulenLWnt signaling in cancer stem cell biologyCancers20168760
- WangLPChenSWZhuangSMLiHSongMGalectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathwayPathol Oncol Res201319346147423519607
- SongSMazurekNLiuCGalectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3 beta activityCancer Res20096941343134919190323
- LiHFLiuYQShenZJDownregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinomaOncol Rep201533265166025421538
- MaruyamaKOchiaiAAkimotoSCytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancerOncology200059430230911096342
- LiangJZhouHPengYβ-Catenin expression negatively correlates with WIF1 and predicts poor clinical outcomes in patients with cervical cancerBiomed Res Int20162016492390327843945
- JiangSSWengDSWangQJGalectin-3 is associated with a poor prognosis in primary hepatocellular carcinomaJ Transl Med20141227325260879
- MiyazakiJHokariRKatoSIncreased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodesOncol Rep2002961307131212375039
- EndoKKohnoeSTsujitaEGalectin-3 expression is a potent prognostic marker in colorectal cancerAnticancer Res20052543117312116080575
- LeeJHZhangXShinBKLeeESKimIMac-2 binding protein and galectin-3 expression in mucinous tumours of the ovary: an annealing control primer system and immunohistochemical studyPathology200941322923319291534
- BrustmannHEpidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcomeInt J Gynecol Pathol200827338038918580315
- KimMKSungCODoIGOverexpression of Galectin-3 and its clinical significance in ovarian carcinomaInt J Clin Oncol201116435235821327452
- BodnarLStanczakACierniakSWnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancerJ Ovarian Res201471624499657
- López-KnowlesEZardawiSJMcneilCMCytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patientsCancer Epidemiol Biomarkers Prev201019130130920056651
- LeeCMShvartsmanHDeaversMTbeta-Catenin nuclear localization is associated with grade in ovarian serous carcinomaGynecol Oncol200388336336812648588
- WeinbergerPMAdamBLGourinCGAssociation of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinomaArch Otolaryngol Head Neck Surg2007133550351017515507
- AhmedRASheblAMHabashyHOExpression levels of β-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray studyCancer Biol Med201714331932628884048
- ZhangLZhouHLiXEya3 partners with PP2A to induce c-Myc stabilization and tumor progressionNat Commun201891104729535359
- AlvesMRE MeloNCBarros-FilhoMCDownregulation of AGR2, p21, and cyclin D and alterations in p53 function were associated with tumor progression and chemotherapy resistance in epithelial ovarian carcinomaCancer Med Epub2018529
- KornmannMDanenbergKDArberNBegerHGDanenbergPVKorcMInhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genesCancer Res199959143505351110416617